• Jobs
  • Startups
  • Hire
LoginSign up
Organization banner, image 1 of 2
Organization banner, image 2 of 2

Role description

Join Our Talent Network Here

Parallel Bio logoParallel BioYC S21
TypeFull-time
WorkplaceRemote
LocationRemote
Posted12/30/2025
Other

The Mission

Drug discovery has a translation problem: more than 95% of drugs that succeed in animal models fail in humans. We're building the alternative: human-first drug discovery, powered by organoids and AI, running on real human biology from the very first experiment.

Our platform is 87% concordant with clinical patient data - a vast improvement over the 3% translational success rate of animals. We’ve demonstrated the ability to model immunotoxicology, immunogen stimulation, and two autoimmune diseases with more on the way. Numerous pharma partners including 3 Fortune 500 companies are already using the platform. We've raised ~$30M from AIX Ventures, Marc Benioff, Jeff Dean, and Y Combinator. With the FDA Modernization Act 3.0 and the FDA's March 2026 validation framework, the regulatory tailwinds only continue to get stronger.

The opportunity ahead of the company is generational: build the first scaled engine for generating real human biological data, and use it to fundamentally change how medicines are discovered.

You may not see a role that applies to your experience now, however, we are always looking for exceptional talent to join our mission.

Submit your resume and tell us what you’re looking for so we can reach out as soon as a relevant position opens up.

Parallel Bio is an equal opportunity employer committed to fostering an inclusive and respectful workplace. We encourage applications from individuals of all backgrounds, regardless of age, gender, ethnicity, religion, disability, or sexual orientation.

Relevant archetypes

Apply on Ashby
Save

Company info

Parallel Bio logo

Parallel Bio

Using the immune system to cure disease

Series AYC S21
HQBrisbane, United States
Size11–50 employees
IndustryBiotechnology Research
Unlock human wisdom
ThesisTermsPrivacy
Funding
  • Series A · Jun 11, 2025
News
  • Parallel Bio Appoints Jason Lew Chief AI Officer to Advance Human-First Drug Discovery
  • Parallel Bio Appoints Jason Lew as Chief AI Officer to Build the Human Data Layer that AI Drug Discovery Is Missing
  • Parallel Bio Appoints Jason Lew as Chief AI Officer to Build the Human Data Layer that AI Drug Discovery Is Missing

Claim parallel.bio

Work at parallel.bio? Sign in to claim this org and manage its profile.

© 2026 Saywise Inc.